Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel nAChR ligands prepared as potential cognitive enhancers

Dec. 10, 1997

Sibia Neurosciences reports promising phase I data for SIB-1508Y

Dec. 10, 1997

CRF antagonists from DuPont Merck for anxiety, depression and related disorders

Dec. 9, 1997

Safe and effective new D2 partial agonist in development at Wyeth-Ayerst

Dec. 9, 1997

Novel valproic acid prodrug reported at scientific meeting

Dec. 9, 1997

New antihyperalgesic agents from Adolor

Dec. 9, 1997

Pfizer improves on NMDA antagonists

Dec. 9, 1997

New muscarinic compound from Wyeth-Ayerst

Dec. 9, 1997

Novo Nordisk develops A1 agonist with neuroprotectant activity

Dec. 9, 1997

Novel therapeutic for anxiety and depression enters phase I

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...